New Guidelines Strongly Recommend the Use of Weight Loss Drugs to Treat Obesity

Today the American Gastroenterology Association (AGA) released new evidence-based guidelines that strongly recommend, for the first time, the long-term use of four approved anti-obesity medications for adult patients who haven’t been able to successfully lose weight through lifestyle changes alone. The new recommendations will be published in the November 2022 issue of Gastroenterology.

“There have been changes in obesity treatment in recent years. This guideline is the first since diabetes drugs were approved for obesity treatment and provides clear information for doctors and their adult patients who struggle to lose weight or keep it off with lifestyle changes alone,” said a coauthor of the findings, Perica Davitkov, MD, a professor in the department of medicine at Case Western Reserve University in Cleveland, Ohio, in a press release.

Weight Loss Medications Are First-Line Medical Options

If a person weighs more than what is considered healthy for their height, they have overweight or obesity. Body mass index (BMI) is one measurement of these conditions; it’s calculated based on a person’s weight and height, and the same formula is used for both men and women. A person with BMI from 25 to 29.9 is considered overweight, and a person with a BMI of over 30 is considered to be obese.

Weight loss medications are first-line medical options and should be used along with healthy eating and regular physical activity, according to the guidelines. Four medications have been approved and shown to result in moderate weight loss as a percentage of body weight (reported as the difference compared with a percentage of weight loss observed in the placebo group).


Leave a Reply

Your email address will not be published. Required fields are marked *